Predicting the clinical course of Hodgkin lymphoma.
Fabbri
Alberto
A
Gozzetti
Alessandro
A
Forconi
Francesco
F
Lauria
Francesco
F
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D018450:Disease Progression; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007150:Immunohistochemistry; D008264:Macrophages / Q000276:immunology; D049268:Positron-Emission Tomography; D011379:Prognosis; D016896:Treatment Outcome; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D019788:Fluorodeoxyglucose F18; C067980:CD68 antigen, human; D000097382:CD68 Molecule